Total raised
$520K
Last: Pre-Seed 2024-09
Stage
Pre-Seed
Founded
2024
Headcount
8
HQ
Jerusalem
Sector
Health Tech & Life Sciences
About
GenoCure.AI is transforming oncology by integrating advanced AI with deep genomic analysis to personalize cancer treatment strategies. The company provides physicians, healthcare providers, and pharmaceutical companies with actionable insights to enhance therapeutic efficacy and improve patient outcomes. The company developed the Supreme™ Platform - a proprietary system that combines multi-omic data with AI-driven algorithms to identify effective therapeutic combinations tailored to each patient's unique tumor profile.
GenoCure.AI aims to bridge the gap between scientific discoveries and clinical applications in oncology.
Funding history · 1 round · $520K total
2024-09
Pre-Seed
$520K
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- When was GenoCure.AI founded?
- GenoCure.AI was founded in February 2024.
- What is GenoCure.AI's primary focus?
- GenoCure.AI focuses on transforming oncology by integrating advanced AI with deep genomic analysis to personalize cancer treatment strategies.
- What is the name of GenoCure.AI's proprietary platform?
- GenoCure.AI developed the Supreme™ Platform, which combines multi-omic data with AI-driven algorithms to identify effective therapeutic combinations.
- What was GenoCure.AI's last funding round?
- In September 2024, GenoCure.AI completed a Pre-Seed funding round, raising a total of $520,000. Hadasit was an investor in this round. For full financing history, please refer to startupim.
- How many employees does GenoCure.AI currently have?
- GenoCure.AI currently has 8 employees.
- Who is a founder of GenoCure.AI?
- Eitan Rubinow is a founder of GenoCure.AI.
- What are the target markets for GenoCure.AI?
- GenoCure.AI targets geographic markets including Asia, Americas, North America, and Europe.
- What business models does GenoCure.AI utilize?
- GenoCure.AI uses B2B2C and B2B business models.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical Biotechnology
Technologies
Artificial IntelligenceBiologicals
Target customers
Healthcare & Life Sciences
Business model
B2B2CB2B
Highlights
1 PatentsVerified
Tags
digital-healthcarehealthcareartificial-intelligencemachine-learningsaasalgorithmsprecision-medicinecancercloud-platformmolecular-biology